These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 24525511)

  • 1. Activating GNAS mutations in parosteal osteosarcoma.
    Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
    Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions.
    Tabareau-Delalande F; Collin C; Gomez-Brouchet A; Decouvelaere AV; Bouvier C; Larousserie F; Marie B; Delfour C; Aubert S; Rosset P; de Muret A; Pagès JC; de Pinieux G
    Mod Pathol; 2013 Jul; 26(7):911-21. PubMed ID: 23370769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.
    Salinas-Souza C; De Andrea C; Bihl M; Kovac M; Pillay N; Forshew T; Gutteridge A; Ye H; Amary MF; Tirabosco R; Toledo SR; Baumhoer D; Flanagan AM
    Mod Pathol; 2015 Oct; 28(10):1336-42. PubMed ID: 26248895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
    Pollandt K; Engels C; Kaiser E; Werner M; Delling G
    Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues.
    Jour G; Oultache A; Sadowska J; Mitchell T; Healey J; Nafa K; Hameed M
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):660-667. PubMed ID: 26574629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.
    Sugiura Y; Kanda H; Motoi N; Nomura K; Inamura K; Okada E; Matsumoto H; Shimoji T; Matsumoto S; Nakayama J; Takazawa Y; Ishikawa Y; Machinami R
    Pathol Res Pract; 2018 Feb; 214(2):318-324. PubMed ID: 29268950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.
    Lee SE; Lee EH; Park H; Sung JY; Lee HW; Kang SY; Seo S; Kim BH; Lee H; Seo AN; Ahn G; Choi YL
    Hum Pathol; 2012 Aug; 43(8):1234-42. PubMed ID: 22245114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw.
    Shi RR; Li XF; Zhang R; Chen Y; Li TJ
    Mod Pathol; 2013 Aug; 26(8):1023-31. PubMed ID: 23503642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
    Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
    Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of activating alpha subunit of the G protein (Gsα) mutation by pyrosequencing in fibrous dysplasia and other bone lesions.
    Liang Q; Wei M; Hodge L; Fanburg-Smith JC; Nelson A; Miettinen M; Foss RD; Wang G
    J Mol Diagn; 2011 Mar; 13(2):137-42. PubMed ID: 21354047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on Carter et al's "activating GNAS mutations in parosteal osteosarcoma".
    Tabareau-Delalande F; Collin C; Larousserie F; Bouvier C; Gomez-Brouchet A; Aubert S; Guinebretière JM; Decouvelaere AV; de Muret A; Pagès JC; de Pinieux G
    Am J Surg Pathol; 2015 Jul; 39(7):1010-3. PubMed ID: 25970689
    [No Abstract]   [Full Text] [Related]  

  • 12. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.
    Idowu BD; Al-Adnani M; O'Donnell P; Yu L; Odell E; Diss T; Gale RE; Flanagan AM
    Histopathology; 2007 May; 50(6):691-704. PubMed ID: 17493233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty.
    Wagoner HA; Steinmetz R; Bethin KE; Eugster EA; Pescovitz OH; Hannon TS
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():395-400. PubMed ID: 17982386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
    Shin SJ; Lee SJ; Kim SK
    Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome.
    Zhadina M; Roszko KL; Geels RES; de Castro LF; Collins MT; Boyce AM
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1482-1490. PubMed ID: 33512531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protuberant fibro-osseous lesions of the temporal bone: two additional case reports.
    Lee M; Song JS; Chun SM; Lee JH; Hong SH; Cho KJ
    Am J Surg Pathol; 2014 Nov; 38(11):1510-5. PubMed ID: 25118809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
    Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
    J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
    Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.
    Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.